Navigation Links
Codexis Opens Singapore Laboratory
Date:10/24/2007

SINGAPORE, Oct. 24 /PRNewswire/ -- Codexis, Inc., a private biotechnology company and leading developer of clean manufacturing processes, today announced the opening of Codexis Laboratories Singapore Pte. Ltd. (CLS). CLS is the company's first research facility in Asia, and is an expansion of the company's research and development operations in the U.S. and Europe. CLS will support the company's pharmaceuticals business in both the innovator and generics markets.

The Guest of Honor at the laboratory opening ceremony was Mr. S. Iswaran, Minister of State for Trade and Industry. Other guests included Chu Swee Yeok, Bio*One Chief Executive Officer, Alan Shaw, Ph.D., Codexis President and Chief Executive Officer, Thomas Baruch, Chairman of the Board and other members of the company's Board of Directors. Bio*One Capital led the Codexis Series D private financing round in August 2006.

"Our expansion to Singapore is a significant part of our global development strategy," Dr. Shaw said. "Singapore offers us access to a highly skilled workforce, proximity to our growing customer base in Asia, and a productive business environment as our company grows. Codexis Laboratories Singapore will play an important role in the development of new products serving our pharmaceuticals markets worldwide."

"We are pleased that Codexis, one of the top biocatalyst companies in the world, has chosen to set up its research facility in Singapore," said Mr. S. Iswaran. "This investment is indeed a strong endorsement for our ability to host such cutting-edge R&D activities, and will, no doubt, contribute to ensuring the long-term sustainability of our pharmaceuticals manufacturing sector."

"Bio*One is delighted to welcome Codexis to Singapore," said Ms. Swee-Yeok Chu. "Our investment in Codexis reflects Bio*One's strong support for innovative biomedical sciences companies with cutting-edge technology that will significantly impact the growth of the biomedical industry in Singapore. We are pleased to be able to play a role in Codexis' expansion plans in Asia to further the company's growth."

The 20,000-square foot research and development center is in the Galen, in the Science Park III area of Singapore. When fully staffed, it is expected to house up to 70 R&D and operations personnel.

Codexis, Inc., a clean technology company, is a leading developer of biocatalytic process technologies that can substantially reduce the cost of manufacturing across a broad range of industries. These technologies enable novel solutions for efficient, cost-effective and environmentally-friendly processes for pharmaceutical, energy and industrial chemical applications. In 2006, the U.S. EPA recognized Codexis with a Presidential Green Chemistry Challenge Award. Codexis is a registered trademark of Codexis, Inc. For more information, please visit http://www.codexis.com.

Contact: Singapore: Cecilia Tan or Alicia Thong, Foreword Communications

Pte Ltd, cecilia@foreword.com.sg or alicia@foreword.com.sg, +65 6338-5918.

US: Justin Jackson, jjackson@burnsmc.com, Burns McClellan, work,

212-213-0006, cell, 917-535-3248 or Lyn Christenson,

lyn.christenson@codexis.com, 650-298-5368


'/>"/>
SOURCE Codexis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. NanoRite Innovation Center opens with small science, big promise
2. TomoTherapy opens technical training center
3. Japanese telecom opens liason office at UW-Platteville
4. Test center for RFID capabilities opens next week
5. Eau Claire business-plan contest opens
6. GE Healthcare opens facility meant for 2,000 employees
7. Space Place opens new astronomy center
8. Research on fruit flies opens up possibilities for human treatments
9. Paper technology transfer center opens in Green Bay
10. Nanotech exhibit opens at UW-Madison
11. Doyles Japan trip opens doors and minds for Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)...  Regular discussions on a range of subjects including policies, ... entities said Poloz. Speaking at a lecture to ... he pointed to the country,s inflation target, which is set ... "In certain areas there needs ... economic goals, why not sit down and address strategy together?" ...
Breaking Biology Technology:
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
Breaking Biology News(10 mins):